Vanda Pharmaceuticals
VNDA
#7861
Rank
โ‚น28.61 B
Marketcap
โ‚น484.22
Share price
3.65%
Change (1 day)
18.16%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น26.38 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has โ‚น26.38 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น32.13 B-0.57%
2023-12-31โ‚น32.32 B-16.33%
2022-12-31โ‚น38.63 B19.92%
2021-12-31โ‚น32.21 B19.78%
2020-12-31โ‚น26.89 B20.83%
2019-12-31โ‚น22.25 B23.69%
2018-12-31โ‚น17.99 B96.52%
2017-12-31โ‚น9.15 B-4.66%
2016-12-31โ‚น9.60 B0.94%
2015-12-31โ‚น9.51 B15.64%
2014-12-31โ‚น8.22 B2.17%
2013-12-31โ‚น8.05 B22.16%
2012-12-31โ‚น6.59 B-16.3%
2011-12-31โ‚น7.87 B-11.25%
2010-12-31โ‚น8.87 B-6.84%
2009-12-31โ‚น9.52 B326.59%
2008-12-31โ‚น2.23 B-33.2%
2007-12-31โ‚น3.34 B136.8%
2006-12-31โ‚น1.41 B0.69%
2005-12-31โ‚น1.40 B99.09%
2004-12-31โ‚น0.70 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
โ‚น876.17 B 3,220.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚น890.59 B 3,274.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น1.667 T 6,218.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.482 T 5,517.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.346 T 5,000.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
โ‚น0.25 B-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.636 T 6,100.47%๐Ÿ‡บ๐Ÿ‡ธ USA